| Bioactivity | HN0037 is a selective and orally active helicase-primase inhibitor. HN0037 inhibits HSV replication by targeting the viral helicase-primase enzyme complex[1]. |
| CAS | 2233566-79-3 |
| Formula | C20H20N4O3S2 |
| Molar Mass | 428.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hou J, et al. Pharmacokinetics and Safety Study of HN0037, a Novel Anti-Human Herpes Simplex Virus Inhibitor, in Healthy Volunteers. Clin Pharmacol Drug Dev. 2022 Dec;11(12):1467-1473. |
HN0037
CAS: 2233566-79-3 F: C20H20N4O3S2 W: 428.53
HN0037 is a selective and orally active helicase-primase inhibitor. HN0037 inhibits HSV replication by targeting the vir
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.